Genelux (GNLX) Total Current Liabilities (2022 - 2026)

Genelux (GNLX) recorded quarterly Total Current Liabilities of $7.3 million in Q1 2026, up 16.82% quarter-over-quarter from $6.2 million in Q4 2025.

Genelux (GNLX) Total Current Liabilities (2022 - 2026) Analysis & Trends

Genelux's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $7.3 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities changed N/A year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $7.3 million (changed N/A YoY), while the FY2025 annual figure was $6.2 million, down 9.82% from the prior year.
  • Total Current Liabilities was $7.3 million for Q1 2026 at Genelux, up from $6.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $31.6 million in Q4 2022 to a low of $5.1 million in Q3 2025.
  • Historically, Total Current Liabilities has averaged $9.0 million across 5 years, with a median of $6.9 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities tumbled 79.28% in 2023, then rose 20.42% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $31.6 million in 2022, then sank by 79.28% to $6.6 million in 2023, then advanced by 5.32% to $6.9 million in 2024, then slipped by 9.82% to $6.2 million in 2025, then advanced by 16.82% to $7.3 million in 2026.
  • The last three Total Current Liabilities figures came in at $7.3 million (Q1 2026), $6.2 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Genelux 129.36 Mn 129.36 Mn - 7.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.27 Mn
Dec 31, 2025 6.23 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.99 Mn
Dec 31, 2024 6.90 Mn
Sep 30, 2024 5.56 Mn
Jun 30, 2024 5.80 Mn
Mar 31, 2024 7.81 Mn
Dec 31, 2023 6.55 Mn
Sep 30, 2023 8.76 Mn
Dec 31, 2022 31.63 Mn